Morgan Stanley Amphastar Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 677,626 shares of AMPH stock, worth $27.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

677,626

Previous 610,137 11.06%

Holding current value

$27.7 Million

Previous $24.4 Million 34.75%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.99 - $50.09 $2.5 Million - $3.38 Million	67,489 Added 11.06%	677,626 $32.9 Million
Q2 2024 Oct 17, 2024	BUY	$38.65 - $43.48 $1.97 Million - $2.22 Million	51,098 Added 9.14%	610,137 $24.4 Million
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $1.97 Million - $2.22 Million	51,098 Added 9.14%	610,137 $24.4 Million
Q1 2024 Oct 17, 2024	SELL	$42.85 - $63.45 $2.19 Million - $3.24 Million	-51,098 Reduced 8.37%	559,039 $24.5 Million
Q1 2024 Aug 16, 2024	SELL	$42.85 - $63.45 $517,370 - $766,095	-12,074 Reduced 2.11%	559,039 $24.5 Million
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $517,370 - $766,095	-12,074 Reduced 2.11%	559,039 $24.5 Million
Q4 2023 Aug 16, 2024	SELL	$44.49 - $62.93 $1.74 Million - $2.46 Million	-39,024 Reduced 6.4%	571,113 $35.3 Million
Q4 2023 Feb 13, 2024	BUY	$44.49 - $62.93 $574,098 - $812,048	12,904 Added 2.31%	571,113 $35.3 Million
Q3 2023 Nov 15, 2023	SELL	$45.51 - $65.0 $391,659 - $559,390	-8,606 Reduced 1.52%	558,209 $25.7 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $1.67 Million - $2.73 Million	46,772 Added 8.99%	566,815 $32.6 Million
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $2.32 Million - $3.15 Million	-83,005 Reduced 13.76%	520,043 $19.5 Million
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $3 Million - $3.36 Million	-107,336 Reduced 15.11%	603,048 $16.9 Million
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $3.21 Million - $4.39 Million	-116,407 Reduced 14.08%	710,384 $20 Million
Q2 2022 Oct 27, 2022	BUY	$29.79 - $42.29 $7.88 Million - $11.2 Million	264,396 Added 47.01%	826,791 $28.8 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $7.88 Million - $11.2 Million	264,396 Added 47.01%	826,791 $28.8 Million
Q1 2022 Oct 27, 2022	SELL	$22.96 - $36.45 $6.07 Million - $9.64 Million	-264,396 Reduced 31.98%	562,395 $20.2 Million
Q1 2022 May 13, 2022	SELL	$22.96 - $36.45 $1.29 Million - $2.05 Million	-56,347 Reduced 9.11%	562,395 $20.2 Million
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $1.84 Million - $2.36 Million	101,307 Added 19.58%	618,742 $14.4 Million
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $9.23 Million - $11.1 Million	517,435 New	517,435 $9.84 Million

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account